Announcement
13 May 2026
: M42 launches kidney.com, bringing AI-powered education to the global fight against chronic kidney disease

Advancing the Future of Health

M42 combines clinical excellence with AI, advanced technology and genomics to disrupt traditional healthcare models and scale health solutions to serve patients, populations and national systems. Our global network supports our ambition to build a globally-scaled health intelligence platform that improves patient outcomes, expands access and drives measurable impact for communities worldwide.

Markets We Serve

M42 is a global health leader advancing precision, prevention and prediction in health. Headquartered in Abu Dhabi, it operates across key international markets, scaling innovation, enabling collaboration and delivering measurable health impact. Today, its network spans more than 480 facilities across 27 countries.

Global Presence, Local Impact

Middle East

A market-leading regional hub anchored in Abu Dhabi, UAE, with presence across Bahrain and the Kingdom of Saudi Arabia, delivering advanced, integrated healthcare and driving innovation across the region.

  • Saudi Arabia
  • United Arab Emirates
  • Bahrain

Europe

A strong presence across Europe, spanning France, Romania, Spain, Portugal, and other key markets, enabling specialized care, research collaboration, and cross-border innovation.

  • Albania
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Lithuania
  • North Macedonia
  • Poland
  • Portugal
  • Romania
  • Russia
  • Spain
  • Sweden
  • United Kingdom

South America

An expanding footprint across Brazil, Chile, and Uruguay, focused on increasing access to high-quality care and strengthening regional capabilities.

  • Brazil
  • Chile
  • Uruguay

Asia

A strategic growth presence across China, Kazakhstan, Malaysia, and Singapore, where M42 is scaling data-driven, technology-led healthcare and accelerating innovation.

  • China
  • Kazakhastan
  • Malaysia
  • Singapore

North Africa

M42 is expanding in Morocco through strategic partnerships and AI-powered, data-driven solutions to advance diagnostics, research, and patient care.

  • Morocco